Pfizer Inc. (NYSE: PFE) announced today that two Phase 3 studies of Sutent (sunitinib malate) in advanced breast cancer did ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE